跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
LISINOPRIL AUROVITAS 20 MG COMPRIMIDOS EFG - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
LISINOPRIL AUROVITAS 20 MG COMPRIMIDOS EFG
Approved
STANDARD
LISINOPRIL AUROVITAS 20 MG COMPRIMIDOS EFG
Aurovitas Spain, S.A.U.
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Sep 22, 2021
Approval ID
d08a907275893d34
Company
Aurovitas Spain, S.A.U.
Type
Standard
Approval Details
Approval Id
d08a907275893d34
Drug Cima Aemps Name
LISINOPRIL AUROVITAS 20 MG COMPRIMIDOS EFG
Register Number
86216
Holder Company Name
Aurovitas Spain, S.A.U.
Marketing Company Name
Aurovitas Spain, S.A.U.
Authorization Date
2021-09-22
Dosage Form
COMPRIMIDO
Dose
20 mg
Route Of Administration
VÍA ORAL
Prescription Type
Medicamento Sujeto A Prescripción Médica. Tratamiento De Larga Duración
Commercialized
Yes
Company Name
Aurovitas Spain, S.A.U.
Active Ingredients
LISINOPRIL DIHIDRATO
21,74 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Sep 22, 2021
Approval ID
d08a907275893d34
Type
Standard
Back to CIMA-AEMPS Approvals